GLAXOSMITHKLINE PLC

GSK
Delayed Quote. Delayed  - 10/23 11:35:30 am
1343.8GBX +0.48%
Prev.1337.4000
Open1333.2000
High1354.6000
Low1330.2000
Volume5 895 669
Latest news
1d ago
1d ago
2d ago
2d ago
Chart GLAXOSMITHKLINE PLC
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance1 4161 5331 575
Spread/Res.-5,1%-12%-15%
Spread/Supp.0,80%0,80%6,4%
Support1 3331 3331 263
Financials
Sales 2020 34 651 M 45 128 M 45 128 M
Net income 2020 4 791 M 6 239 M 6 239 M
Net Debt 2020 22 730 M 29 602 M 29 602 M
P/E ratio 2020 13,9x
Yield 2020 5,95%
Capitalization 66 890 M 87 270 M 87 114 M
EV / Sales 2020 2,59x
EV / Sales 2021 2,46x
Nbr of Employees 99 437
Free-Float 91,3%
Company
GlaxoSmithkline plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows:
- pharmaceutical products (52%): intended for respiratory diseases (67.5% of net sales), HIV infection (27.7%), immune system disorders (3.5%) ) and cancer (1,3%);
- OTC and...

>> Read more
Sector :
Pharmaceuticals - NEC
Calendar :
2020-10-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 1 806,25 GBX
Last Close Price 1 343,80 GBX
Spread / Highest target 74,9%
Spread / Average Target 34,4%
Spread / Lowest Target -16,7%